{"id":75006,"date":"2026-08-17T15:21:34","date_gmt":"2026-08-17T07:21:34","guid":{"rendered":"https:\/\/flcube.com\/?p=75006"},"modified":"2026-08-17T15:21:35","modified_gmt":"2026-08-17T07:21:35","slug":"guangdong-regulator-issues-recall-traceability-and-emergency-response-rules-for-imported-hong-kong-macao-pharmaceuticals-and-medical-devices-in-gba","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=75006","title":{"rendered":"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The <strong>Guangdong Medical Products Administration<\/strong> issued three landmark policy documents governing imported <strong>Hong Kong and Macao pharmaceuticals and medical devices<\/strong> in the nine mainland cities of the <strong>Guangdong\u2011Hong Kong\u2011Macao Greater Bay Area (GBA)<\/strong>: the <strong>Guidelines for Recall<\/strong>, the <strong>Guidelines for Traceability<\/strong>, and the <strong>Emergency Plan for Safety Incidents (Trial)<\/strong>. Together, the documents establish the first comprehensive lifecycle safety framework for the GBA cross\u2011border medicine and device program.<\/p>\n\n\n\n<h2 id=\"h-policy-overview\" class=\"wp-block-heading\">Policy Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Document<\/th><th>Core Purpose<\/th><\/tr><\/thead><tbody><tr><td><strong>Recall Guidelines<\/strong><\/td><td>Defines workflows, operational procedures, and responsibilities for recalling imported Hong Kong\/Macao pharmaceuticals and medical devices<\/td><\/tr><tr><td><strong>Traceability Guidelines<\/strong><\/td><td>Requires a full\u2011chain traceability system across the nine mainland GBA cities<\/td><\/tr><tr><td><strong>Emergency Plan (Trial)<\/strong><\/td><td>Seven chapters, 25 articles; establishes emergency response criteria and division of responsibilities for safety incidents<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-recall-guidelines-three-trigger-scenarios\" class=\"wp-block-heading\">Recall Guidelines \u2013 Three Trigger Scenarios<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Recall Scenario<\/th><th>Description<\/th><\/tr><\/thead><tbody><tr><td><strong>Overseas Synchronous Recall<\/strong><\/td><td>Triggered when the product is recalled in its origin market<\/td><\/tr><tr><td><strong>Voluntary Recall<\/strong><\/td><td>Initiated by the business operator<\/td><\/tr><tr><td><strong>Mandated Recall<\/strong><\/td><td>Ordered by the regulatory authority<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The <strong>Recall Guidelines<\/strong> require pharmaceutical and medical device business operators and designated medical institutions to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Establish dedicated <strong>recall management systems<\/strong><\/li>\n\n\n\n<li>Store problematic products in <strong>designated areas under dedicated management<\/strong><\/li>\n\n\n\n<li>Submit <strong>progress reports, summary reports, and immediate reports<\/strong> as required<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-traceability-guidelines-full-chain-tracking\" class=\"wp-block-heading\">Traceability Guidelines \u2013 Full\u2011Chain Tracking<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Unique Identification:<\/strong> Business operators must assign a <strong>&#8220;one item, one code&#8221;<\/strong> identifier to each imported product<\/li>\n\n\n\n<li><strong>Platform Integration:<\/strong> Operators must interface with the <strong>provincial regulatory information platform<\/strong><\/li>\n\n\n\n<li><strong>Institution\u2011Level Data Capture:<\/strong> Designated medical institutions must collect and upload traceability information at the <strong>receiving and usage stages<\/strong><\/li>\n\n\n\n<li><strong>Objective:<\/strong> Ensure that products&#8217; <strong>sources can be traced, destinations tracked, and responsibilities assigned<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-emergency-plan-structure\" class=\"wp-block-heading\">Emergency Plan Structure<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Composition:<\/strong> Seven chapters and 25 articles<\/li>\n\n\n\n<li><strong>Governance:<\/strong> Emphasizes division of responsibilities among key departments and establishes a <strong>liaison officer mechanism<\/strong><\/li>\n\n\n\n<li><strong>Primary Responsibility:<\/strong> <strong>Designated medical institutions<\/strong> are designated as the primary responsible entities for safety incidents involving urgently needed imported Hong Kong and Macao pharmaceuticals and medical devices in clinical use<\/li>\n\n\n\n<li><strong>Activation Criteria:<\/strong> Emergency response is triggered based on the <strong>severity of health damage, scope of impact, and social influence<\/strong><\/li>\n\n\n\n<li><strong>Response Scope:<\/strong> Comprehensive emergency response measures across the entire incident process<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Institutionalizing the GBA Program:<\/strong> The three documents convert the pilot cross\u2011border medicine and device scheme into a rules\u2011based system, reducing regulatory uncertainty for hospitals and operators participating in the <strong>GBA<\/strong> program.<\/li>\n\n\n\n<li><strong>Compliance Investment:<\/strong> Full\u2011chain traceability with &#8220;one item, one code&#8221; identifiers will require technology and process upgrades from business operators and designated medical institutions, favoring well\u2011resourced participants.<\/li>\n\n\n\n<li><strong>Patient Safety Signal:<\/strong> Clear recall scenarios and emergency response criteria strengthen the safety case for expanding the list of imported Hong Kong and Macao products permitted in the nine mainland cities.<\/li>\n\n\n\n<li><strong>Integration Precedent:<\/strong> The framework sets a template for deeper regulatory coordination within the Greater Bay Area, potentially accelerating future cross\u2011border healthcare integration initiatives.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The Guangdong Medical Products Administration issued three landmark policy documents governing imported Hong Kong and&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[11,22,4],"tags":[26],"class_list":["post-75006","post","type-post","status-publish","format-standard","hentry","category-drug","category-medical-device","category-policy-regulatory","tag-greater-bay-area"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Guangdong Medical Products Administration issued three landmark policy documents governing imported Hong Kong and Macao pharmaceuticals and medical devices in the nine mainland cities of the Guangdong\u2011Hong Kong\u2011Macao Greater Bay Area (GBA): the Guidelines for Recall, the Guidelines for Traceability, and the Emergency Plan for Safety Incidents (Trial). Together, the documents establish the first comprehensive lifecycle safety framework for the GBA cross\u2011border medicine and device program.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=75006\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA\" \/>\n<meta property=\"og:description\" content=\"The Guangdong Medical Products Administration issued three landmark policy documents governing imported Hong Kong and Macao pharmaceuticals and medical devices in the nine mainland cities of the Guangdong\u2011Hong Kong\u2011Macao Greater Bay Area (GBA): the Guidelines for Recall, the Guidelines for Traceability, and the Emergency Plan for Safety Incidents (Trial). Together, the documents establish the first comprehensive lifecycle safety framework for the GBA cross\u2011border medicine and device program.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=75006\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-17T07:21:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-17T07:21:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75006#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75006\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA\",\"datePublished\":\"2026-08-17T07:21:34+00:00\",\"dateModified\":\"2026-08-17T07:21:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75006\"},\"wordCount\":488,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Greater Bay Area\"],\"articleSection\":[\"Drug\",\"Medical Device\",\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75006#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75006\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=75006\",\"name\":\"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-17T07:21:34+00:00\",\"dateModified\":\"2026-08-17T07:21:35+00:00\",\"description\":\"The Guangdong Medical Products Administration issued three landmark policy documents governing imported Hong Kong and Macao pharmaceuticals and medical devices in the nine mainland cities of the Guangdong\u2011Hong Kong\u2011Macao Greater Bay Area (GBA): the Guidelines for Recall, the Guidelines for Traceability, and the Emergency Plan for Safety Incidents (Trial). Together, the documents establish the first comprehensive lifecycle safety framework for the GBA cross\u2011border medicine and device program.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75006#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75006\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75006#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA - Insight, China&#039;s Pharmaceutical Industry","description":"The Guangdong Medical Products Administration issued three landmark policy documents governing imported Hong Kong and Macao pharmaceuticals and medical devices in the nine mainland cities of the Guangdong\u2011Hong Kong\u2011Macao Greater Bay Area (GBA): the Guidelines for Recall, the Guidelines for Traceability, and the Emergency Plan for Safety Incidents (Trial). Together, the documents establish the first comprehensive lifecycle safety framework for the GBA cross\u2011border medicine and device program.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=75006","og_locale":"en_US","og_type":"article","og_title":"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA","og_description":"The Guangdong Medical Products Administration issued three landmark policy documents governing imported Hong Kong and Macao pharmaceuticals and medical devices in the nine mainland cities of the Guangdong\u2011Hong Kong\u2011Macao Greater Bay Area (GBA): the Guidelines for Recall, the Guidelines for Traceability, and the Emergency Plan for Safety Incidents (Trial). Together, the documents establish the first comprehensive lifecycle safety framework for the GBA cross\u2011border medicine and device program.","og_url":"https:\/\/flcube.com\/?p=75006","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-17T07:21:34+00:00","article_modified_time":"2026-08-17T07:21:35+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=75006#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=75006"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA","datePublished":"2026-08-17T07:21:34+00:00","dateModified":"2026-08-17T07:21:35+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=75006"},"wordCount":488,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Greater Bay Area"],"articleSection":["Drug","Medical Device","Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=75006#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=75006","url":"https:\/\/flcube.com\/?p=75006","name":"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-17T07:21:34+00:00","dateModified":"2026-08-17T07:21:35+00:00","description":"The Guangdong Medical Products Administration issued three landmark policy documents governing imported Hong Kong and Macao pharmaceuticals and medical devices in the nine mainland cities of the Guangdong\u2011Hong Kong\u2011Macao Greater Bay Area (GBA): the Guidelines for Recall, the Guidelines for Traceability, and the Emergency Plan for Safety Incidents (Trial). Together, the documents establish the first comprehensive lifecycle safety framework for the GBA cross\u2011border medicine and device program.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=75006#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=75006"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=75006#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Guangdong Regulator Issues Recall, Traceability and Emergency Response Rules for Imported Hong Kong\u2013Macao Pharmaceuticals and Medical Devices in GBA"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=75006"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75006\/revisions"}],"predecessor-version":[{"id":75007,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75006\/revisions\/75007"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=75006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=75006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=75006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}